Merck & Co., Inc. Stock

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 16:00:02 2024-04-16 EDT 5-day change 1st Jan Change
125.1 USD -0.90% Intraday chart for Merck & Co., Inc. -1.30% +14.71%
Sales 2024 * 63.78B 88.19B Sales 2025 * 68.02B 94.04B Capitalization 317B 438B
Net income 2024 * 19.51B 26.97B Net income 2025 * 21.75B 30.07B EV / Sales 2024 * 5.27 x
Net Debt 2024 * 19.65B 27.17B Net Debt 2025 * 7.53B 10.41B EV / Sales 2025 * 4.77 x
P/E ratio 2024 *
16.1 x
P/E ratio 2025 *
14.1 x
Employees 71,000
Yield 2024 *
2.45%
Yield 2025 *
2.58%
Free-Float 70.75%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.03%
1 week-1.30%
Current month-5.22%
1 month+2.91%
3 months+5.54%
6 months+20.09%
Current year+14.71%
More quotes
1 week
125.03
Extreme 125.03
127.82
1 month
120.38
Extreme 120.38
133.10
Current year
109.16
Extreme 109.16
133.10
1 year
99.14
Extreme 99.14
133.10
3 years
70.89
Extreme 70.89
133.10
5 years
65.25
Extreme 65.25
133.10
10 years
45.69
Extreme 45.69
133.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14-03-31
Director of Finance/CFO 55 89-12-31
Chief Tech/Sci/R&D Officer 55 20-07-31
Members of the board TitleAgeSince
Director/Board Member 63 07-11-26
Director/Board Member 67 15-08-31
Director/Board Member 69 18-02-28
More insiders
Date Price Change Volume
24-04-16 125.1 -0.90% 5,587,315
24-04-15 126.2 +0.36% 6,241,069
24-04-12 125.7 -0.33% 7,369,989
24-04-11 126.2 -0.47% 6,187,364
24-04-10 126.8 +0.03% 5,787,733

Delayed Quote Nyse, April 16, 2024 at 04:00 pm

More quotes
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.1 USD
Average target price
137.2 USD
Spread / Average Target
+9.68%
Consensus